The objective of the present study was therefore to investigate (i) if PET metabolic heterogeneity features reflect the heterogeneity of ER and PR expression within luminal breast tumors and (ii) if PET metabolic heterogeneity features could help in non-invasively identifying patients with the worst event-free survival (EFS). Here, ESR1 is linked to breast neoplasm.